Menu
My ERA Junte-se ao ERA

The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial

Suggestions
My Era Junte-se ao ERA
Home | Video pages | Webcast | Menopause and renal disease

Menopause and renal disease

Diabesity Working Group

Speaker
Esteban Porrini, Spain

Panellists
Anette Tønnes Pedersen, Denmark
Ana Rodríguez, Spain

Moderator
Morten Buus Jørgensen, Denmark

The webcast will be available soon.